Latin, English, French, Spanish:

Recommended INN

Chemical name or description; Molecular formula; Graphic formula

DCI Recommandée

Nom chimique ou description; Formule brute; Formule développée

DCI Recomendada

Nombre químico o descripción; Fórmula empírica; Fórmula desarrollada

acidum gadocoleticum

gadocoletic acid

trihydrogen [3β-[[(4S)-4-[bis[2-[bis[(carboxy-KO)methyl]amino-KN]ethyl]amino-KN]-4-(carboxy-KO)butanoyl]amino]-12α-hydroxy-5β-cholan-24-oato(6-)]=gadolinate(3-)

acide gadocolétique

trihydrogéno[3β-[[(4S)-4-[bis[2-[bis[(carboxy-KO)méthyl]amino-N]éthyl]amino-KN]-4-(carboxy-KO)butanoyl]amino]-12α-hydroxy-5β-cholan-24-oato(6-)]=gadolinate(3-)

ácido gadocolético

trihidrógeno[3β-[[(4S)-4-[bis[2-[bis[(carboxi-KO)metil]amino-KN]etil]amino-KN]-4-(carboxi-KO)butanoil]amino]-12α-hidroxi-5β-colan-24-ato(6-)]gadolinato(3-)

C₄₁H₆₃GdN₄O₁₄

afeletecanum

afeletecan

camptothecin, ester with N-[[p-[(3-O-methyl-β-L-fucopyranosyl)oxy]phenyl]=thiocarbamoyl]-L-histidyl-L-valine

afélétécan

(2S)-2-[[(2S)-3-(1H-imidazol-4-yl)-2-[[[[4-[(3-O-méthyl-6-désoxy-β-L-galactopyranosyl)oxy]phényl]amino]thiocarbonyl]amino]propanoyl]amino]-3-méthylbutanoate de (4S)-4-éthyl-3,14-dioxo-3,4,12,14-tétrahydro-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinoléin-4-yle

afeletecán

ester de la camptotecina con N-[[p-[(3-O-metil-β-L-fucopiranosil)oxi]fenil]=tiocarbamoil]-L-histidil-L-valina

C₄₅H₄₉N₇O₁₁S

alfimeprasum

alfimeprase

[3-L-serine]fibrolase-(3-203)-peptide (fibrolase: fibrinolytic enzyme isolated from Agkistrodon contrix contrix venom)

alfiméprase

[3-L-sérine]fibrolase-(3-203)-peptide (fibrolase: enzyme fibrinolytique extraite de venin d’Agkistrodon contrix contrix)

alfimeprasa

[3-L-serina]fibrolasa-(3-203)-péptido (fibrolasa: enzime fibrinolítica extraida de veneno de Agkistrodon contrix contrix)

C₉₈₅H₁₅₄₁N₂₈₅O₃₀₁S₁₂

alicaforsenum

alicaforsen

2’-deoxy-(R)-P-thioguanylyt-(3’→5’)-2’-deoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-deoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-deoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-deoxy-(R)-P-thioadenylyl-(3’→5’)-2’-deoxy-(R)-P-thioadenylyl-(3’→5’)-2’-deoxy-(R)-P-thioguanylyl-(3’→5’)-2’-deoxy-(R)-P-thiocytidylyl-(3’→5’)-(R)-P-thiothymidylyl-(3’→5’)-2’-deoxy-(R)-P-thioguanylyl-(3’→5’)-2’-deoxy-(R)-P-thioguanylyl-(3’→5’)-2’-deoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-deoxy-(R)-P-thioadenylyl-(3’→5’)-(R)-P-thiothymidylyl-(3’→5’)-2’-deoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-deoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-deoxy-(R)-P-thioguanylyl-(3’→5’)-(R)-P-thiothymidylyl-(3’→5’)-2’-deoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-deoxyadenosine nonadecasodium salt

alicaforsen

2’-désoxy-(R)-P-thioguanylyl-(3’→5’)-2’-désoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-désoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-désoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-désoxy-(R)-P-thioadénylyl-(3’→5’)-2’-désoxy-(R)-P-thioadénylyl-(3’→5)-2’-désoxy-(R)-P-thioguanylyl-(3’→5’)-2’-désoxy-(R)-P-thiocytidylyl-(3’→5’)-(R)-P-thiothymidylyl-(3’→5’)-2’-désoxy-(R)-P-thioguanylyl-(3’→5’)-2’-désoxy-(R)-P-thioguanylyl-(3’→5’)-2’-désoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-désoxy-(R)-P-thioadénylyl-(3’→5’)-(R)-P-thiothymidylyl-(3’→5’)-2’-désoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-désoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-désoxy-(R)-P-thioguanylyl-(3’→5’)-(R)-P-thiothymidylyl-(3’→5’)-2’-désoxy-(R)-P-thiocytidylyl-(3’→5’)-2’-désoxyadénosine nonadécasodique

alicaforseno

2’-desoxi-(R)-P-tioguanilil-(3’→5’)-2’-desoxi-(R)-P-tiocitidilil-(3’→5’)-2’-desoxi-(R)-P-tiocitidilil-(3’→5’)-2’-desoxi-(R)-P-tiocitidilil-(3’→5’)-2’-desoxi-(R)-P-tioadenilil-(3’→5’)-2’-desoxi-(R)-P-tioadenilil-(3’→5’)-2’-desoxi-(R)-P-tioguanilil-(3’→5’)-2’-desoxi-(R)-P-tiocitidilil-(3’→5’)-(R)-P-tiotimidilil-(3’→5’)-2’-desoxi-(R)-P-tioguanilil-(3’→5’)-2’-desoxi-(R)-P-tioguanilil-(3’→5’)-2’-desoxi-(R)-P-tiocitidilil-(3’→5’)-2’-desoxi-(R)-P-tioadenilil-(3’→5’)-(R)-P-tiotimidilil-(3’→5’)-2’-desoxi-(R)-P-tiocitidilil-(3’→5’)-2’-desoxi-(R)-P-tiocitidilil-(3’→5’)-2’-desoxi-(R)-P-tioguanilil-(3’→5’)-(R)-P-tiotimidilil-(3’→5’)-2’-desoxi-(R)-P-tiocitidilil-(3’→5’)-2’-desoxiadenosina nonadecasódica

C₁₉₂H₂₂₅N₇₅Na₁₉O₉₈P₁₉S₁₉

alilusemum

alilusem

7-chloro-1-(2-methylbenzoyl)-2,3-dihydroquinolin-4(1H)-one (E)-O-sulfooxime

alilusem

(E)-O-sulfooxime de 7-chloro-1-(2-méthylbenzoyl)-2,3-dihydroquinoléin-4(1H)-one

alilusem

(E)-O-sulfooxima de 7-cloro-1-(2-metilbenzoil)-2,3-dihidroquinolin-4(1H)-ona

C₁₇H₁₅ClN₂O₅S

ambrisentanum

ambrisentan

(+)-(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic acid

ambrisentan

(+)-acide (2S)-2-[(4,6-diméthylpyrimidin-2-yl)oxy]-3-méthoxy-3,3-diphénylpropanoïque

ambrisentán

(+)-ácido (2S)-2-[(4,6-dimetilpirimidin-2-il)oxi]-3-metoxi-3,3-difenilpropanoico

C₂₂H₂₂N₂O₄

amdoxovirum

amdoxovir

[(2R,4R)-4-(2,6-diamino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol

amdoxovir

[(2R,4R)-4-(2,6-diamino-9H-purin-9-yl)-1,3-dioxolan-2-yl]méthanol

amdoxovir

[(2R,4R)-4-(2,6-diamino-9H-purin-9-il)-1,3-dioxolan-2-il]metanol

C₉H₁₂N₆O₃

amelubantum

amelubant

ethyl [[4-[[3-[[4-[1-(4-hydroxyphenyl)-1-methylethyl]phenoxy]methyl]benzyl]=oxy]phenyl](imino)methyl]carbamate

amélubant

[[4-[[3-[[4-[1-(4-hydroxyphényl)-1-méthyléthyl]phénoxy]méthyl]benzyl]oxy]=phényl](imino)méthyl]carbamate d’éthyle

amelubant

[[4-[[3-[[4-[1-(4-hidroxifenil)-1-metiletil]fenoxi]metil]bencil]oxi]fenil](imino)metil]=carbamato de etilo

C₃₃H₃₄N₂O₅

amotosalenum

amotosalen

3-[(2-aminoethoxy)methyl]-2,5,9-trimethyl-7H-furo[3,2-g][1]benzopyran-7-one

amotosalène

3-[(2-aminoéthoxy)méthyl]-2,5,9-triméthyl-7H-furo[3,2-g][1]benzopyran-7-one

amotosaleno

3-[(2-aminoetoxi)metil]-2,5,9-trimetil-7H-furo[3,2-g][1]benzopiran-7-ona

C₁₇H₁₉NO₄

bimatoprostum

bimatoprost

(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-N-ethyl-5-heptenamide

bimatoprost

(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phénylpent-1-ényl]cyclopentyl]-N-éthylhept-5-énamide

bimatoprost

(Z)-7-[(1R,2R,3R,5S)-3,5-dihidroxi-2-[(1E,3S)-3-hidroxi-5-fenilpent-1-enil]ciclopentil]-N-etilhept-5-enamida

C₂₅H₃₇NO₄

caldaretum

caldaret

5-methyl-2-(piperazin-1-yl)benzenesulfonic acid

caldaret

acide 5-méthyl-2-(pipérazin-1-yl)benzènesulfonique

caldaret

ácido 5-metil-2-(piperazin-1-il)bencenosulfónico

C₁₁H₁₆N₂O₃S

cipralisantum

cipralisant

4-[(1R,2R)-2-(5,5-dimethylhex-1-ynyl)cyclopropyl]-1H-imidazole

cipralisant

4-[(1R,2R)-2-(5,5-diméthylhex-1-ynyl)cyclopropyl]-1H-imidazole

cipralisant

4-[(1R,2R)-2-(5,5-dimetilhex-1-inil)ciclopropil]-1H-imidazol

C₁₄H₂₀N₂

darbepoetinum alfa

darbepoetin alfa

[30-L-asparagine,32-L-thronine,87-L-valine,88-L-asparagine, 90-L-threonine]erythropoietin (human)

darbépoétine alfa

[30-L-asparagine,32-L-thréonine,87-L-valine,88-L-asparagine, 90-L-thréonine]érythropoiétine humaine

darbepoetina alfa

[30-L-asparagina,32-L-treonina,87-L-valina,88-L-asparagina, 90-L-treonina]eritropoietina humana

C₈₀₀H₁₃₀₀N₂₂₈O₂₄₃S₅

drotrecoginum alfa (activatum)

drotrecogin alfa (activated)

blood coagulation factor XIV (human)

drotrécogine alfa (activé)

facteur XIV humain de coagulation sanguine

drotrecogina alfa (activada)

factor XIV de coagulación sanguínea (humano)

C₂₀₇₁H₃₁₆₅N₅₈₁O₆₄₀S₃₁

ecalcidenum

ecalcidene

1-[(5Z,7E,20S)-1α,3β-dihydroxy-9,10-secochola-5,7,10(19)-trien-24-oyl]piperidine

écalcidène

1-[(5Z,7E,20S)-1α,3β-dihydroxy-9,10-sécochola-5,7,10(19)-trién-24-oyl]pipéridine

ecalcideno

1-[(5Z,7E,20S)-1α,3β-dihidroxi-9,10-secocola-5,7,10(19)-trien-24-oil]piperidina

C₂₉H₄₅NO₃

efalizumabum

efalizumab

immunoglobulin G1, anti-(human antigen CD11a) (human-mouse monoclonal hu1124 γ1-chain), disulfide with human-mouse monoclonal hu1124 light chain, dimer

éfalizumab

immunoglobuline G1, anti-(antigène CD11a humain) (chaîne γ1 de l’anticorps monoclonal de souris humanisé hu1124), dimère du disulfure avec la chaîne légère de l’anticorps monoclonal de souris humanisé hu1124

efalizumab

inmunoglobulina G1, anti-(antígeno CD11a humano) (cadena γ1 del anticuerpo monoclonal humanizado de ratón hu1124), dímero del disulfuro con la cadena ligera del anticuerpo monoclonal humanizado de ratón hu1124

enfuvirtidum

enfuvirtide

acetyl-L-tyrosyl-L-threonyl-L-seryl-L-leucyl-L-isoleucyl-L-histidyl-L-seryl-L-leucyl-L-isoleucyl-L-α-glutamyl-L-α-glutamyl-L-seryl-L-glutaminyl-L-asparaginyl-L-glutaminyl-L-glutaminyl-L-α-glutamyl-L-lysyl-L-asparaginyl-L-α-glutamyl-L-glutaminyl-L-α-glutamyl-L-leucyl-L-leucyl-L-α-glutamyl-L-leucyl-L-α-aspartyl-L-lysyl-L-tryptophyl-L-alanyl-L-seryl-L-leucyl-L-tryptophyl-L-asparaginyl-L-tryptophyl-L-phenylalaninamide

enfuvirtide

acétyl-L-tyrosyl-L-thréonyl-L-séryl-L-leucyl-L-isoleucyl-L-histidyl-L-séryl-L-leucyl-L-isoleucyl-L-α-glutamyl-L-α-glutamyl-L-séryl-L-glutaminyl-L-asparaginyl-L-glutaminyl-L-glutaminyl-L-α-glutamyl-L-lysyl-L-asparaginyl-L-α-glutamyl-L-glutaminyl-L-α-glutamyl-L-leucyl-L-leucyl-L-α-glutamyl-L-leucyl-L-α-aspartyl-L-lysyl-L-tryptophyl-L-alanyl-L-séryl-L-leucyl-L-tryptophyl-L-asparaginyl-L-tryptophyl-L-phénylalaninamide

enfuvirtida

acetil-L-tirosil-L-treonil-L-seril-L-leucil-L-isoleucil-L-histidil-L-seril-L-leucil-L-isoleucil-L-α-glutamil-L-α-glutamil-L-seril-L-glutaminil-L-asparaginil-L-glutaminil-L-glutaminil-L-α-glutamil-L-lisil-L-asparaginil-L-α-glutamil-L-glutaminil-L-α-glutamil-L-leucil-L-leucil-L-α-glutamil-L-leucil-L-α-aspartil-L-lisil-L-triptofil-L-alanil-L-seril-L-leucil-L-triptofil-L-asparaginil-L-triptofil-L-fenilalaninamida

C₂₀₄H₃₀₁N₅₁O₆₄

epafipasum

epafipase

2-acetyl-1-alkyl-sn-glycero-3-phosphocholine deacetylase-(6-400)-peptide (human)

épafipase

désacétylase-(6-400)-peptide (humaine) de la 2-acétyl-1-alkyl-sn-glycéro-3-phosphocholine

epafipasa

1-O-alquil-2-acetil-sn-glicero-3-fosfocolina 6-400-desacetilasa (humana)

C₂₀₁₆H₃₁₀₇N₅₄₅O₅₈₆S₁₄

epoetinum delta

epoetin delta

1-165-erythropoietin (human HMR4396), glycoform δ

époétine delta

1-165-érythropoiétine (humaine HMR4396), glycoforme δ

epoetina delta

1-165-eritropoietina (humana HMR4396), glicoforma δ

C₈₀₉H₁₃₀₁N₂₂₉O₂₄₀S₅

erlotinibum

erlotinib

N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine

erlotinib

N-(3-éthynylphényl)-6,7-bis(2-méthoxyéthoxy)quinazolin-4-amine

erlotinib

N-(3-etinilfenil)-6,7-bis(2-metoxietoxi)quinazolin-4-amina

C₂₂H₂₃N₃O₄

febuxostatum

febuxostat

2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid

fébuxostat

acide 2-[3-cyano-4-(2-méthylpropoxy)phényl]-4-méthylthiazole-5-carboxylique

febuxostat

ácido 2-[3-ciano-4-(2-metilpropoxi)fenil]-4-metiltiazol-5-carboxílico

C₁₆H₁₆N₂O₃S

feloprentanum

feloprentan

(2S)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3,3-diphenylpropanoic acid

féloprentan

acide (2S)-3-[2-(3,4-diméthoxyphényl)éthoxy]-2-[(4,6-diméthylpyrimidin-2-yl)oxy]-3,3-diphénylpropanoïque

feloprentán

ácido (2S)-3-[2-(3,4-dimetoxifenil)etoxi]-2-[(4,6-dimetilpirimidin-2-il)oxi]-3,3-difenilpropanoico

C₃₁H₃₂N₂O₆

finafloxacinum

finafloxacin

(-)-8-cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

finafloxacine

(-)-acide 8-cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl)-4-oxo-1,4-dihydroquinoléine-3-carboxylique

finafloxacino

(-)-ácido 8-ciano-1-ciclopropil-6-fluoro-7-[(4aS,7aS)-hexahidropirrolo[3,4-b]-1,4-oxazin-6(2H)-il)-4-oxo-1,4-dihidroquinolina-3-carboxílico

C₂₀H₁₉FN₄O₄

gadomelitolum

gadomelitol

hydrogen [2,2’,2’’,2’’’-[1,4,7,10-tetraazacyclododecane-1,4,7,10-triyl]tetrakis=[5-[[2-[[4-[[4-[[2-[[3,5-bis[bis[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl-2,4,6-tribromo]carbamoyl]phenyl]amino]-2-oxoethyl]carbamoyl]phenyl]=carbamoyl]phenyl]amino]-2-oxoethyl]amino]-5-oxopentanoato](4-)]=gadolinate(1-)

gadomélitol

hydrogéno-[2,2’,2’’,2’’’-[1,4,7,10-tétraazacyclododécane-1,4,7,10-triyl]tétrakis [5-[[2-[[4-[[4-[[2-[[3,5-bis[bis[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl-2,4,6-tribromo]carbamoyl]phényl]amino]-2-oxoéthyl]carbamoyl]phényl]=carbamoyl]phényl]amino]-2-oxoéthyl]amino]-5-oxopentanoato](4-)]=gadolinate(1-)

gadomelitol

hidrógeno-[2,2’,2’’,2’’’-[1,4,7,10-tetraazaciclododecano-1,4,7,10-triil]tetrakis=[5-[[2-[[4-[[4-[[2-[[3,5-bis[bis[(2S,3R,4R,5R)-2,3,4,5,6-pentahidroxihexil-2,4,6-tribromo]carbamoil]fenil]amino]-2-oxoetil]carbamoil]fenil]carbamoil]fenil]=amino]-2-oxoetil]amino]-5-oxopentanoato](4-)]gadolinato(1-)

C₂₂₈H₃₁₃Br₁₂GdN₃₂O₁₁₆

garnocestimum

garnocestim

5-73-macrophage inflammatory protein 2α (human gene gro2)

garnocestim

CXC chimiokine GROβ-(5-73)-peptide (GROβ: protéine inflammatoire humaine sécrétée par les macrophages)

garnocestim

CXC quimiokina GROβ-(5-73)-péptido (GROβ: proteína inflamatoria humana secretada por los macrófagos)

C₃₂₅H₅₅₇N₉₇O₉₅S₆

gefitinibum

gefitinib

N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine

géfitinib

N-(3-chloro-4-fluorophényl)-7-méthoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine

gefitinib

N-(3-cloro-4-fluorofenil)-7-metoxi-6-[3-(morfolin-4-il)propoxi]quinazolin-4-amina

C₂₂H₂₄ClFN₄O₃

ingliforibum

ingliforib

5-chloro-N-[(1S,2R)-1-benzyl-3-(cis-3,4-dihydroxypyrrolidin-1-yl)-2-hydroxy-3-oxopropyl]-1H-indole-2-carboxamide

ingliforib

5-chloro-N-[(1S,2R)-1-benzyl-3-(cis-3,4-dihydroxypyrrolidin-1-yl)-2-hydroxy-3-oxopropyl]-1H-indole-2-carboxamide

ingliforib

5-cloro-N-[(1S,2R)-1-bencil-3-(cis-3,4-dihidroxipirrolidin-1-il)-2-hidroxi-3-oxopropil]-1H-indol-2-carboxamida

C₂₃H₂₄ClN₃O₅

ipravacainum

ipravacaine

(2RS)-1-(cyclopropylmethyl)-2’,6’-dimethyl-2-piperidinecarboxanilide

ipravacaïne

(2RS)-1-(cyclopropylméthyl)-N-(2,6-diméthylphényl)pipéridine-2-carboxamide

ipravacaína

(2RS)-1-(ciclopropilmetil)-N-(2,6-dimetilfenil)piperidina-2-carboxamida

C₁₈H₂₆N₂O

isegananum

iseganan

L-arginylglycylglycyl-L-leucyl-L-cysteinyl-L-tyrosyl-L-cysteinyl-L-arginylglycyl-L-arginyl-L-phenylalanyl-L-cysteinyl-L-valyl-L-cysteinyl-L-valylglycyl-L-argininamide cyclic (5→14),(7→12)-bis(disulfide)

iséganan

(5→14),(7→12)-bis(disulfure cyclique) de L-arginyl-glycyl-glycyl-L-leucyl-L-cystéinyl-L-tyrosyl-L-cystéinyl-L-arginyl-glycyl-L-arginyl-L-phénylalanyl-L-cystéinyl-L-valyl-L-cystéinyl-L-valyl-glycyl-L-argininamide

iseganán

(5→14),(7→12)-bis(disulfuro cíclico) de L-arginil-glicil-glicil-L-leucil-L-cisteinil-L-tirosil-L-cisteinil-L-arginil-glicil-L-arginil-L-fenilalanil-L-cisteinil-L-valil-L-cisteinil-L-valil-glicil-L-argininamida

C₇₈H₁₂₆N₃₀O₁₈S₄

labetuzumabum

labetuzumab

immunoglobulin G, anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14γ-chain), disulfide with human-mouse monoclonal hMN-14K-chain, dimer

labétuzumab

immunoglobuline G, anti-(antigène carcinoembryonnaire humain) (chaîne-γ de l’anticorps monoclonal de souris humanisé hMN-14), dimère du disulfure avec la chaîne-K de l’anticorps monoclonal de souris humanisé hMN-14

labetuzumab

inmunoglobulina G, anti-(antígeno carcinoembrionario humano) (cadena-γ del anticuerpo monoclonal humanizado de ratón hMN-14), dímero del disulfuro con la cadena-K del anticuerpo monoclonal humanizado de ratón hMN-14

laniquidarum

laniquidar

methyl 6,11-dihydro-11-[1-[2-[4-(-2-quinolylmethoxy)phenyl]ethyl]-4-piperidinylidene]-5H-imidazo[2,1-b][3]benzazepine-3-carboxylate

laniquidar

11-[1-[2-[4-(quinoléin-2-ylméthoxy)phényl]éthyl]pipéridin-4-ylidène]-6,11-dihydro-5H-imidazo[2,1-b][3]benzazépine-3-carboxylate de méthyle

laniquidar

11-[1-[2-[4-(quinolin-2-ilmetoxi)fenil]etil]piperidin-4-ilideno]-6,11-dihidro-5H-imidazo[2,1-b][3]benzazepina-3-carboxilato de metilo

C₃₇H₃₆N₄O₃

lapisteridum

lapisteride

N-[1-(4-methoxyphenyl)-1-methylethyl]-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide

lapistéride

N-[1-(4-méthoxyphényl)-1-méthyléthyl]-3-oxo-4-aza-5α-androst-1-ène-17β-carboxamide

lapisterida

N-[1-(4-metoxifenil)-1-metiletil]-3-oxo-4-aza-5α-androst-1-eno-17β-carboxamida

C₂₉H₄₀N₂O₃

laquinimodum

laquinimod

5-chloro-N-ethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide

laquinimod

5-chloro-N-éthyl-4-hydroxy-1-méthyl-2-oxo-N-phényl-1,2-dihydroquinoléine-3-carboxamide

laquinimod

5-cloro-N-etil-4-hidroxi-1-metil-2-oxo-N-fenil-1,2-dihidroquinolina-3-carboxamida

C₁₉H₁₇ClN₂O₃

laronidasum

laronidase

8-L-histidine-α-L-iduronidase (human)

laronidase

[8-L-histidine]-α-L-iduronidase humaine

laronidasa

8-L-histidina-α-L-iduronidasa (humana)

C₃₁₆₉H₄₈₅₄N₉₀₁O₈₈₄S₁₂

lirimilastum

lirimilast

2-(2,4-dichlorobenzoyl)-3-ureidobenzofuran-6-yl methanesulfonate

lirimilast

méthanesulfonate de 2-(2,4-dichlorobenzoyl)-3-uréidobenzofuran-6-yle

lirimilast

metanosulfonato de 2-(2,4-diclorobenzoil)-3-ureidobenzofuran-6-ilo

C₁₇H₁₂Cl₂N₂O₆S

livaraparinum calcium

livaraparin calcium

calcium salt of a low molecular mass heparin that is obtained by nitrous acid depolymerization of heparin from porcine intestinal mucosa; the majority of the components have a 2-O-sulfo-α-L-idopyranosuronic acid structure at the non-reducing end and a 6-O-sulfo-structure at the reducing end of their chain; the mass-average molecular mass ranges between 3000 and 5000 with 75% is less than 8000; the degree of sulfatation is approximately 2 per disaccharidic unit

livaraparine calcique

sel calcique d’une héparine de basse masse moléculaire obtenue par dépolymérisation, au moyen d’acide nitreux, d’héparine de muqueuse intestinale de porc; la majorité des composants de la livaraparine calcique possèdent une structure acide 2-O-sulfo-α-L-idopyranosuronique à l’extrémité non réductrice de leur chaîne et une structure 6-O-sulfatée à l’extrémité réductrice de leur chaîne; la masse moléculaire relative moyenne est de 3000 à 5000, 75% étant inférieur à 8000; le degré de sulfatation par unité disaccharide est voisin de 2

livaraparina cálcica

sal cálcica de una heparina de baja masa molecular obtenida de heparina de mucosa intestinal de cerdo por despolimerización con ácido nitroso; la mayoría de los componentes de la livaraparina cálcica tienen ácido 2-O-sulfo-α-L-idopiranosurónico en el extremo no reductor de la cadena y una estructura 6-O-sulfatada en el extremo reductor de la cadena; la masa molecular relativa media es de 3000 a 5000, siendo el 75% inferior a 8000; el grado de sulfatación por unidad de disacárido es aproximadamente 2

manifaxinum

manifaxine

(2S,3S,5R)-2-(3,5-difluorophenyl)-3,5-dimethylmorpholin-2-ol

manifaxine

(2S,3S,5R)-2-(3,5-difluorophényl)-3,5-diméthylmorpholin-2-ol

manifaxina

(2S,3S,5R)-2-(3,5-difluorofenil)-3,5-dimetilmorfolin-2-ol

C₁₂H₁₅F₂NO₂

miglustatum

miglustat

(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol

miglustat

(2R,3R,4R,5S)-1-butyl-2-(hydroxyméthyl)pipéridine-3,4,5-triol

miglustat

(2R,3R,4R,5S)-1-butil-2-(hidroximetil)piperidina-3,4,5-triol

C₁₀H₂₁NO₄

miriplatinum

miriplatin

(SP-4-2)-[(1R,2R)-cyclohexane-1,2-diamine-N,N]=bis(tetradecanoato-O)platinum

miriplatine

(SP-4-2)-[(1R,2R)-cyclohexane-1,2-diamine-N,N]=bis(tétradécanoato-O)platine

miriplatino

(SP-4-2)-[(1R,2R)-ciclohexano-1,2-diamina-N,N’]=bis(tetradecanoato-O)platino

C₃₄H₆₈N₂O₄Pt

mirostipenum

mirostipen

[23-methionine]human myeloid progenitor inhibitory factor 1-(23-99)-peptide

mirostipen

[23-méthionine]facteur 1 d’inhibition du précurseur myéloïde humain-(23-99)-peptide

mirostipeno

[23-metionina]-(23-99)-péptido del factor 1 de inhibición del progenitor mieloide humano

C₃₈₀H₆₁₄N₁₁₂O₁₁₃S₉

mureletecanum

mureletecan

poly[[N-(2-hydroxypropyl)methacrylamide]-co-[camptothecin ester with N-[6-(2-methacrylamidoacetamido)hexanoyl]glycine]-co-[N-[[(2-hydroxypropyl)carbamoyl]methyl]methacrylamide]]

murélétécan

copolymère de N-[(2RS)-2-hydroxypropyl]-2-méthylpropénamide, de N-[2-[[6-[[2-[[(4S)-4-éthyl-3,14-dioxo-3,4,12,14-tétrahydro-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinoléin-4-yl]oxy]-2-oxoéthyl]amino]-6-oxohexyl]amino]-2-oxoéthyl]-2-méthylpropénamide et de N-[2-[[(2RS)-2-hydroxypropyl]amino]-2-oxoéthyl]-2-méthylpropénamide

mureletecán

poli[[N-(2-hidroxipropil)metacrilamida]-co-[éster de camptotecina con N-[6-(2-metacrilamidoacetamido)hexanoil]glicina]-co-[N-[[(2-hidroxipropil)carbamoil]metil]metacrilamida]]

nasaruplasum beta

beta nasaruplase beta

prourokinase (enzyme-activating) human (clone pUK4/pUK18 protein moiety), glycosylated (murine cell line SP2/0)

nasaruplase bêta

prourokinase (activateur d’enzyme) humaine glycosylée dont le gène est cloné dans le vecteur pUK4/pUK18 et exprimée dans la lignée cellulaire murine SP2/0

nasaruplasa beta

prourokinasa (activador de enzima) humana glicosilada cuyo gen se clona en el vector pUK4/pUK18 y se expresa en la línea celular murina SP2/0

C₂₀₃₁H₃₁₂₁N₅₈₅O₆₀₁S₃₁

netoglitazonum

netoglitazone

(5RS)-5-[[6-[(2-fluorophenyl)methoxy]naphthalen-2-yl]methyl]thiazolidine-2,4-dione

nétoglitazone

(5RS)-5-[[6-[(2-fluorophényl)méthoxy]naphtalén-2-yl]méthyl]thiazolidine-2,4-dione

netoglitazona

(5RS)-5-[[6-[(2-fluorofenil)metoxi]naftalen-2-il]metil]tiazolidina-2,4-diona

C₂₁H₁₆FNO₃S

ospemifenum

ospemifene

2-[p-[(Z)-4-chloro-1,2-diphenyl-1-butenyl]phenoxy]ethanol

ospémifène

(Z)-2-[4-(4-chloro-1,2-diphénylbut-1-ényl)phénoxy]éthanol

ospemifeno

2-[p-[(Z)-4-cloro-1,2-difenil-1-butenil]fenoxi]etanol

C₂₄H₂₃ClO₂

pegfilgrastimum

pegfilgrastim

N-(3-hydroxypropyl)methionylcolony-stimulating factor (human), 1-ether with α-methyl-ω)-hydroxypoly(oxyethylene)

pegfilgrastim

N-(3-hydroxypropyl)méthionylfacteur de stimulation de colonie humain, 1-éther avec le α-méthyl-ω-hydroxypoly(oxyéthylène)

pegfilgrastim

N-(3-hidroxipropil)metionilfactor de estimulación de colonias humano, 1-éter con el α-metil-ω-hidroxipoli(oxietileno)

C₈₄₉H₁₃₄₇N₂₂₃O₂₄₄S₉,(C₂H₄O)_n

pexelizumabum

pexelizumab

immunoglobulin, anti-(human complement C5 α-chain) (human-mouse monoclonal 5G1.1-SC single chain)

pexélizumab

immunoglobuline, anti-(chaîne-α du complément C5 humain) (mono chaîne de l’anticorps monoclonal de souris humanisé 5G1.1-SC)

pexelizumab

inmunoglobulina, anti-(cadena-α del complemento C5 humano) (mono cadena del anticuerpo monoclonal humanizado de ratón 5G1.1-SC)

pralnacasanum

pralnacasan

(1S,9S)-N-[(2R,3S)-2-ethoxy-5-oxotetrahydrofuran-3-yl]-9-[(isoquinolin-1-ylcarbonyl)amino]-6,10-dioxooctahydro-6-H-pyridazino[1,2-a][1,2]=diazepine-1-carboxamide

pralnacasan

(1S,9S)-N-[(2R,3S)-2-éthoxy-5-oxotétrahydrofuran-3-yl]-9-[(isoquinoléin-1-ylcarbonyl)amino]-6,10-dioxooctahydro-6-H-pyridazino[1,2-a]=[1,2]diazepine-1-carboxamide

pralnacasán

(1S,9S)-N-[(2R,3S)-2-etoxi-5-oxotetrahidrofuran-3-il]-9-[(isoquinolin-1-ilcarbonil)amino]-6,10-dioxooctahidro-6-H-piridazino[1,2-a][1,2]diazepina-1-carboxamida

C₂₆H₂₉N₅O₇

pratosartanum

pratosartan

2-propyl-3-[[2’-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-5,6,7,8-tetrahydrocycloheptaimidazol-4(3H)-one

pratosartan

2-propyl-3-[[2’-(1H-tétrazol-5-yl)biphényl-4-yl]méthyl]-5,6,7,8-tétrahydrocycloheptaimidazol-4(3H)-one

pratosartán

2-propil-3-[[2’-(1H-tetrazol-5-il)bifenil-4-il]metil]-5,6,7,8-tetrahidrocicloheptaimidazol-4(3H)-ona

C₂₅H₂₆N₆O

ragaglitazarum

ragaglitazar

(-)-(2S)-2-ethoxy-3-[4-[2-(10H-phenoxazin-10-yl)ethoxy]phenyl]propanoic acid

ragaglitazar

(-)-acide (2S)-2-éthoxy-3-[4-[2-(10H-phénoxazin-10-yl)éthoxy]phényl]=propanoïque

ragaglitazar

(-)-ácido (2S)-2-etoxi-3-[4-[2-(10H-fenoxazin-10-il)etoxi]fenil]propanoico

C₂₅H₂₅NO₅

reslizumabum

reslizumab

immunoglobulin G4, anti-(human interleukin 5) (human-rat monoclonal SCH 55700 γ4-chain), disulfide with human-rat monoclonal SCH 55700 light chain, dimer

reslizumab

immunoglobuline G4, anti-(interleukine 5 humaine), (chaîne γ4 de l’anticorps monoclonal de rat humanisé SCH 55700), dimère du disulfure avec la chaîne légère de l’anticorps monoclonal de rat humanisé SCH 55700

reslizumab

immunoglobulina G4, anti-(interleukina 5 humana), (cadena γ4 del anticuerpo monoclonal humanizado de rata SCH 55700), dímero del disulfuro con la cadena ligera del anticuerpo monoclonal humanizado de rata SCH 55700

ruboxistaurinum

ruboxistaurin

(9S)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,19H-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-18,20-dione

ruboxistaurine

(9S)-9-[(diméthylamino)méthyl]-6,7,10,11-tétrahydro-9H,19H-5,21:12,17-diméthénodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadécène-18,20-dione

ruboxistaurina

(9S)-9-[(dimetilamino)metil]-6,7,10,11-tetrahidro-9H,19H-5,21:12,17-dimetenodibenzo[e,k]pirrolo[3,4-h][1,4,13]oxadiazaciclohexadeceno-18,20-diona

C₂₈H₂₈N₄O₃

semaxanibum

semaxanib

3-[(Z)-(3,5-dimethylpyrrol-2-yl)methylene]-2-indolinone

sémaxanib

(Z)-3-[(3,5-diméthyl-1H-pyrrol-2-yl)méthylène]-1,3-dihydro-2H-indol-2-one

semaxanib

3-[(Z)-(3,5-dimetilpirrol-2-il)metileno]-2-indolinona

C₁₅H₁₄N₂O

senazodanum

senazodan

6-[4-(pyridin-4-ylamino)phenyl]-4,5-dihydropyridazin-3(2H)-one

sénazodan

6-[4-(pyridin-4-ylamino)phényl]-4,5-dihydropyridazin-3(2H)-one

senazodán

6-[4-(piridin-4-ilamino)fenil]-4,5-dihidropiridazin-3(2H)-ona

C₁₅H₁₄N₄O

silodosinum

silodosin

(-)-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]=ethyl]amino]propyl]-2,3-dihydro-1H-indole-7-carboxamide

silodosine

(-)-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroéthoxy)phénoxy]=éthyl]amino]propyl]-2,3-dihydro-1H-indole-7-carboxamide

silodosina

(-)-1-(3-hidroxipropil)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroetoxi)fenoxi]etil]=amino]propil]-2,3-dihidro-1H-indol-7-carboxamida

C₂₅H₃₂F₃N₃O₄

solifenacinum

solifenacin

(3R)-1-azabicyclo[2.2.2]oct-3-yl(1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate

solifénacine

(1S)-1-phényl-3,4-dihydroisoquinoléine-2(1H)-carboxylate de (3R)-1-azabicyclo[2.2.2]oct-3-yle

solifenacina

(1S)-1-fenil-3,4-dihidroisoquinolina-2(1H)-carboxilato de (3R)-1-azabiciclo[2.2.2]oct-3-ilo

C₂₃H₂₆N₂O₂

tadalafilum

tadalafil

(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1’,2’:1,6]pyrido[3,4-b]indole-1,4-dione

tadalafil

(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1’,2’:1,6]pyrido[3,4-b]indole-1,4-dione

tadalafilo

(6R,12aR)-6-(1,3-benzodioxol-5-il)-2-metil-2,3,6,7,12,12a-hexahidropirazino[1’,2’:1,6]pirido[3,4-b]indol-1,4-diona

C₂₂H₁₉N₃O₄

tafluposidum

tafluposide

4-[(5R,5aR,8aR,9S)-9-[[4,6-O-[(1R)-ethylidene]-2,3-bisO-[(pentafluorophenoxy)acetyl]-β-D-glucopyranosyl]oxy]-6-oxo-5,5a,6,8,8a,9-hexahydrofuro[3’,4’:6,7]naphtho[2,3-d]-1,3-dioxol-5-yl]-2,6-dimethoxyphenyle dihydrogen phosphate

tafluposide

dihydrogénophosphate de 4-[(5R,5aR,8aR,9S)-9-[[4,6-O-[(1R)-éthylidène]-2,3-bisO-[(pentafluorophénoxy)acétyl]-β-D-glucopyranosyl]oxy]-6-oxo-5,5a,6,8,8a,9-hexahydrofuro[3’,4’:6,7]naphto[2,3-d]-1,3-dioxol-5-yl]-2,6-diméthoxyphényle

taflupósido

dihidrógenofosfato de 4-[(5R,5aR,8aR,9S)-9-[[4,6-O-[(1R)-etilideno]-2,3-bisO-[(pentafluorofenoxi)acetil]-β-D-glucopiranosil]oxi]-6-oxo-5,5a,6,8,8a,9-hexahidrofuro[3’,4’:6,7]nafto[2,3-d]-1,3-dioxol-5-il]-2,6-dimetoxifenilo

C₄₅H₃₅F₁₀O₂₀P

telberminum

telbermin

vascular endothelial growth factor (human), dimer

telbermine

facteur de croissance de l’endothélium vasculaire humain (dimère)

telbermina

factor de crecimiento del endotelio vascular (humano), dímero

C₁₆₁₂H₂₅₃₆N₅₀₀O₄₉₈S₄₄

tenivastatinum

tenivastatin

(3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-[(2,2-dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphtalen-1-yl]-3,5-dihydroxyheptanoic acid

ténivastatine

acide (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-[(2,2-diméthylbutanoyl)oxy]-2,6-diméthyl-1,2,6,7,8,8a-hexahydronaphtalén-1-yl]-3,5-dihydroxyheptanoïque

tenivastatina

ácido (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-[(2,2-dimetilbutanoil)oxi]-2,6-dimetil-1,2,6,7,8,8a-hexahidronaftalen-1-il]-3,5-dihidroxiheptanoico

C₂₅H₄₀O₆

tesaglitazarum

tesaglitazar

(2S)-2-ethoxy-3-[4-[2-[4-[(methylsulfonyl)oxy]phenyl]ethoxy]phenyl]=propanoic acid

tésaglitazar

acide (2S)-2-éthoxy-3-[4-[2-[4-[(méthylsulfonyl)oxy]phényl]éthoxy]phényl]=propanoïque

tesaglitazar

ácido (2S)-2-etoxi-3-[4-[2-[4-[(metilsulfonil)oxi]fenil]etoxi]fenil]propanoico

C₂₀H₂₄O₇S

tofimilastum

tofimilast

9-cyclopentyl-7-ethyl-3-(thiophen-2-yl)-6,9-dihydro-5H-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-a]pyridine

tofimilast

9-cyclopentyl-7-éthyl-3-(thiophén-2-yl)-6,9-dihydro-5H-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-a]pyridine

tofimilast

9-ciclopentil-7-etil-3-(tiofen-2-il)-6,9-dihidro-5H-pirazolo[3,4-c]-1,2,4-triazolo[4,3-a]piridina

C₁₈H₂₁N₅S

xidecaflurum

xidecaflur

2,2-[(9Z)-9-octadecenylimino]diethanol hydrofluoride

xidécaflur

fluorhydrate de 2,2’-[(9Z)-octadec-9-énylimino]diéthanol

xidecaflur

hidrofluoruro de 2,2-[(9Z)-9-octadecenilimino]dietanol

C₂₂H₄₆FNO₂

zanapezilum

zanapezil

3-(1-benzylpiperidin-4-yl)-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)propan-1-one

zanapézil

3-(1-benzylpipéridin-4-yl)-1-(2,3,4,5-tétrahydro-1H-benzazépin-8-yl)propan-1-one

zanapezilo

3-(1-bencilpiperidin-4-il)-1-(2,3,4,5-tetrahidro-1H-1-benzazepin-8-il)propan-1-ona

C₂₅H₃₂N₂O

zonampanelum

zonampanel

[7-(1H-imidazol-1-yl)-6-nitro-2,3-dioxo-3,4-dihydroquinoxalin-1(2H)-yl]acetic acid

zonampanel

acide [7-(1H-imidazol-1-yl)-6-nitro-2,3-dioxo-3,4-dihydroquinoxalin-1(2H)-yl]acétique

zonampanel

ácido [7-(1H-imidazol-1-il)-6-nitro-2,3-dioxo-3,4-dihidroquinoxalin-1(2H)-il]acético

C₁₃H₉N₅O₆

zoniporidum

zoniporide

N-carbamimidoyl-5-cyclopropyl-1-(quinolin-5-yl)-1H-pyrazole-4-carboxamide

zoniporide

N-carbamimidoyl-5-cyclopropyl-1-(quinoléin-5-yl)-1H-pyrazole-4-carboxamide

zoniporida

N-carbamimidoil-5-ciclopropil-1-(quinolin-5-il)-1H-pyrazol-4-carboxamida

C₁₇H₁₆N₆O

zoticasonum

zoticasone

S-[(3R)-2-oxotetrahydrofuran-3-yl] 6α,9-difluoro-12β,17-dihydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioate

zoticasone

6α,9-difluoro-12β,17-dihydroxy-16α-méthyl-3-oxoandrosta-1,4-diène-17β-carbothioate de S-[(3R)-2-oxotétrahydrofuran-3-yle]

zoticasona

6α,9-difluoro-12β,17-dihidroxi-16α-metil-3-oxoandrosta-1,4-dieno-17β-carbotioato de S-[(3R)-2-oxotetrahidrofuran-3-ilo]

C₂₅H₃₀F₂O₆S

Proposed International Nonproprietary Names (Prop. INN): List 59
Dénominations communes internationales proposées (DCI Prop.): Liste 59
Denominaciones Comunes Internacionales Propuestas (DCI Prop.): Lista 59
(WHO Drug Information/Informations pharmaceutiques OMS/Informaciones farmacéuticas de la OMS, Vol. 2, No. 2, 1988)

p. 16

delete/supprimer/suprimase

insert/insérer/insértese

levoglutamidum

glutaminum

levoglutamide

glutamine

lévoglutamide

glutamine

levoglutamida

glutamina

Recommended International Nonproprietary Names (Rec. INN): List 42
Dénominations communes internationales recommandées (DCI Rec.): Liste 42
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 42
(WHO Drug Information, Vol. 13, No. 3, 1999)

suprimase

insértese

p. 184

carabersato

carabersat

p. 207

tonabersato

tonabersat

Recommended International Nonproprietary Names (Rec. INN): List 44
Dénominations communes internationales recommandées (DCI Rec.): Liste 44
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 44
(WHO Drug Information, Vol. 14, No. 3, 2000)

p. 199

delete/supprimer/suprimase

insert/insérer/insértese

nebostinelum

neboglaminum

nebostinel

neboglamine

nébostinel

néboglamine

nebostinel

neboglamina

p. 199

onerceptum

onercept

replace the description by the following:
TNF-BP-(20-180)-peptide (part of extracellular domain of the glycosylated human Tumor Necrosis Factor Receptor 1)

onercept

sustitúyase la descripción por la siguiente:
péptido (20-180) TNF-BP (parte del dominio extracelular del receptor 1 humano del factor de necrosis tumoral glicosilado)

Recommended International Nonproprietary Names (Rec. INN): List 45
Dénominations communes internationales recommandées (DCI Rec.): Liste 45
Denominaciones Comunes Internacionales Recomendadas (DCI Rec.): Lista 45
(WHO Drug Information, Vol. 15, No. 1, 2001)

p. 55

evernimicinum

evernimicina

sustitúyase la descripción por la siguiente:
O-3-C-metil-4-O-metil-3-nitro-2,3,6-tridesoxi-α-L-arabino-hexopiranosil-(1→3)-O-4-O-(3,5-dicloro-4-hidroxi-2-metoxi-6-metilbenzoil)-2,6-didesoxi-β-D-arabino-hexopiranosil-(1→4)-O-(1R)-2,6-didesoxi-D-arabino-hexopiranosilideno-(1→3-4)-O-3-C-metil-6-desoxi-β-D-manopiranosil-(1→3)-O-4-O-metil-6-desoxi-β-D-galactopiranosil-(1→4)-2,6-di-O-metil-β-D-manopiranosido de O-(1R)-4-O-(2,4-dihidroxi-6-metilbenzoil)-2,3-O-metileno-D-xilopiranosilideno-(1→3-4)-α-L-lixopiranosilo

Procedure and Guiding Principles/Procédure et Directives/Procedimientos y principios generales

The text of the Procedures for the Selection of Recommended International Nonproprietary Names for Pharmaceutical Substances and General Principles for Guidance in Devising International Nonproprietary Names for Pharmaceutical Substances will be reproduced in uneven numbers of proposed INN lists only.

Les textes de la Procédure à suivre en vue du choix de dénominations communes internationales recommandées pour les substances pharmaceutiques et des Directives générales pour la formation de dénominations communes internationales applicables aux substances pharmaceutiques seront publiés seulement dans les numéros impaires des listes des DCIs proposées.

El texto de los Procedimientos de selección de denominaciones comunes internacionales recomendadas para las sustancias farmacéuticas y de los Principios generales de orientación para formar denominaciones comunes internacionales para sustancias farmacéuticas aparece solamente en los números impares de las listas de DCI propuestas.